These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27445423)

  • 1. Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer.
    Marrugal Á; Ojeda L; Paz-Ares L; Molina-Pinelo S; Ferrer I
    Dis Markers; 2016; 2016():2138627. PubMed ID: 27445423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of proteomics in non-small-cell lung cancer.
    Cho WC
    Expert Rev Proteomics; 2016; 13(1):1-4. PubMed ID: 26577456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke.
    Babu N; Advani J; Solanki HS; Patel K; Jain A; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Mathur PP; Nair B; Keshava Prasad TS; Chang X; Sidransky D; Gowda H; Chatterjee A
    Microrna; 2018; 7(1):38-53. PubMed ID: 29299995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic biomarkers for lung cancer progression.
    Ren Y; Zhao S; Jiang D; Feng X; Zhang Y; Wei Z; Wang Z; Zhang W; Zhou QF; Li Y; Hou H; Xu Y; Zhou F
    Biomark Med; 2018 Mar; 12(3):205-215. PubMed ID: 29424557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic biomarkers of non-small cell lung cancer patients.
    Baran K; Brzeziańska-Lasota E
    Adv Respir Med; 2021; 89(4):419-426. PubMed ID: 34494245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics biomarkers for non-small cell lung cancer.
    Kisluk J; Ciborowski M; Niemira M; Kretowski A; Niklinski J
    J Pharm Biomed Anal; 2014 Dec; 101():40-9. PubMed ID: 25175018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic and genomic biomarkers for Non-Small Cell Lung Cancer: Peroxiredoxin, Haptoglobin, and Alpha-1 antitrypsin.
    Najafi Z; Mohamadnia A; Ahmadi R; Mahmoudi M; Bahrami N; Khosravi A; Jamaati H; Tabarsi P; Kazem Pour Dizaji M; Shirian S
    Cancer Med; 2020 Jun; 9(11):3974-3982. PubMed ID: 32232956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach.
    Pan ST; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():937-68. PubMed ID: 25733813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
    Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
    Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
    Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
    Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer.
    Li QR; Liu YS; Zeng R
    Methods Mol Biol; 2017; 1619():385-394. PubMed ID: 28674898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Proteomic Analysis of Optimal Cutting Temperature (OCT) Embedded Core-Needle Biopsy of Lung Cancer.
    Zhao X; Huffman KE; Fujimoto J; Canales JR; Girard L; Nie G; Heymach JV; Wistuba II; Minna JD; Yu Y
    J Am Soc Mass Spectrom; 2017 Oct; 28(10):2078-2089. PubMed ID: 28752479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially expressed and activated proteins associated with non small cell lung cancer tissues.
    Nigro E; Imperlini E; Scudiero O; Monaco ML; Polito R; Mazzarella G; Orrù S; Bianco A; Daniele A
    Respir Res; 2015 Jun; 16(1):74. PubMed ID: 26104294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in Non-Small Cell Lung Cancer: Perspectives of Individualized Targeted Therapy.
    Aoki MN; Amarante MK; de Oliveira CEC; Watanabe MAE
    Anticancer Agents Med Chem; 2018; 18(15):2070-2077. PubMed ID: 30147015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer.
    Chuang JC; Liang Y; Wakelee HA
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):31-44. PubMed ID: 27912832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of direct targets for the miR-17-92 cluster by proteomic analysis.
    Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K; Ouchida M
    Proteomics; 2011 Sep; 11(17):3531-9. PubMed ID: 21751348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.